ATE209906T1 - Trägerstoff zur verzögerten freisetzung - Google Patents

Trägerstoff zur verzögerten freisetzung

Info

Publication number
ATE209906T1
ATE209906T1 AT95914917T AT95914917T ATE209906T1 AT E209906 T1 ATE209906 T1 AT E209906T1 AT 95914917 T AT95914917 T AT 95914917T AT 95914917 T AT95914917 T AT 95914917T AT E209906 T1 ATE209906 T1 AT E209906T1
Authority
AT
Austria
Prior art keywords
delayed release
release carrier
cross
heteropolysaccharide
linking
Prior art date
Application number
AT95914917T
Other languages
English (en)
Inventor
Anand R Baichwal
Troy W Mccall
Original Assignee
Mendell Co Inc Edward
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendell Co Inc Edward filed Critical Mendell Co Inc Edward
Application granted granted Critical
Publication of ATE209906T1 publication Critical patent/ATE209906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Character Spaces And Line Spaces In Printers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
  • Push-Button Switches (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Superstructure Of Vehicle (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT95914917T 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung ATE209906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23262594A 1994-04-25 1994-04-25
PCT/US1995/003825 WO1995028916A1 (en) 1994-04-25 1995-03-21 Sustained release excipient

Publications (1)

Publication Number Publication Date
ATE209906T1 true ATE209906T1 (de) 2001-12-15

Family

ID=22873888

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01112778T ATE308318T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung
AT95914917T ATE209906T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01112778T ATE308318T1 (de) 1994-04-25 1995-03-21 Trägerstoff zur verzögerten freisetzung

Country Status (18)

Country Link
EP (2) EP1145712B1 (de)
JP (1) JP3279318B2 (de)
KR (1) KR100232020B1 (de)
CN (1) CN1131023C (de)
AT (2) ATE308318T1 (de)
AU (1) AU705378B2 (de)
CA (1) CA2164513C (de)
DE (2) DE69524358T2 (de)
DK (1) DK0706377T3 (de)
ES (2) ES2246961T3 (de)
FI (1) FI119353B (de)
HK (1) HK1040487B (de)
HU (1) HU219818B (de)
IL (1) IL113167A (de)
MX (1) MX9600022A (de)
PT (1) PT706377E (de)
TW (1) TW357085B (de)
WO (1) WO1995028916A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044952A1 (en) 1997-04-04 1998-10-15 Monsanto Company pH-SELECTIVE DELIVERY SYSTEM USING CROSS-LINKED POLYMERIC RESINS AS VEHICLES
WO1998044951A2 (en) * 1997-04-04 1998-10-15 Monsanto Company Hydrolysable delivery system using cross-linked polymeric resins as vehicles
US6890524B1 (en) 1997-04-04 2005-05-10 Monsanto Company Hydrolyzable delivery system using cross-linked polymeric resins as vehicles
CA2452872A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
CA2459976A1 (en) * 2001-09-26 2003-04-03 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
WO2003086353A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
KR101999055B1 (ko) * 2018-02-28 2019-10-01 경북대학교 산학협력단 과황산 이온 서방성 구조체, 이의 제조방법 및 이를 이용한 유기 오염 물질 처리 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303691A (en) * 1977-11-09 1981-12-01 Anderson, Clayton & Co. Proteinaceous food product
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5399358A (en) * 1993-11-12 1995-03-21 Edward Mendell Co., Inc. Sustained release formulations for 24 hour release of metroprolol
US5399362A (en) * 1994-04-25 1995-03-21 Edward Mendell Co., Inc. Once-a-day metoprolol oral dosage form

Also Published As

Publication number Publication date
EP0706377B1 (de) 2001-12-05
EP0706377A1 (de) 1996-04-17
MX9600022A (es) 1998-06-30
JPH08512061A (ja) 1996-12-17
AU705378B2 (en) 1999-05-20
AU2198295A (en) 1995-11-16
KR100232020B1 (ko) 1999-12-01
WO1995028916A1 (en) 1995-11-02
ES2164764T3 (es) 2002-03-01
EP0706377A4 (de) 1996-11-06
DE69524358D1 (de) 2002-01-17
EP1145712B1 (de) 2005-11-02
HK1040487B (zh) 2006-05-12
HK1040487A1 (en) 2002-06-14
IL113167A (en) 2001-01-28
DK0706377T3 (da) 2002-04-02
HUT73636A (en) 1996-08-28
CA2164513C (en) 1999-09-21
HU9503456D0 (en) 1996-02-28
CN1131023C (zh) 2003-12-17
HU219818B (hu) 2001-08-28
TW357085B (en) 1999-05-01
KR960703016A (ko) 1996-06-19
JP3279318B2 (ja) 2002-04-30
IL113167A0 (en) 1995-06-29
EP1145712A1 (de) 2001-10-17
DE69534575D1 (de) 2005-12-08
PT706377E (pt) 2002-05-31
ES2246961T3 (es) 2006-03-01
DE69524358T2 (de) 2002-06-13
CN1127469A (zh) 1996-07-24
FI956209A (fi) 1995-12-22
CA2164513A1 (en) 1995-11-02
FI119353B (fi) 2008-10-31
DE69534575T2 (de) 2006-07-13
FI956209A0 (fi) 1995-12-22
ATE308318T1 (de) 2005-11-15

Similar Documents

Publication Publication Date Title
EP0515312A3 (en) Pharmaceutical composition containing terbinafine as an anti-mycotic agent
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
IL112637A0 (en) A pharmaceutical composition containing oxybutynin and methods for the preparation thereof
HUT75881A (en) Pharmaceutical composition for 24 hour release of metoprolol
GB2263115B (en) Composition for dental restoration
SG28285A1 (en) Method for molding dental restorations and related apparatus
BR9609537A (pt) Composições farmacêuticas
IT1242170B (it) Composizione adesiva stabilizzante per protesi dentarie.
FR2627984B1 (fr) Composition pulverulente a base d'alginate pour empreintes dentaires
GB2292153B (en) Silicone composition for dental impressions
EP0461586A3 (en) Dental composition for impression-taking
IT9048524A0 (it) Composizione adesiva stabilizzante per protesi dentarie.
EP0476925A3 (en) Uv light-curable organopolysiloxane composition
DE69524358T2 (de) Trägerstoff zur verzögerten freisetzung
DE59109272D1 (de) Mehrkomponentenmaterial und Verfahren zu seiner Herstellung
CS240991A3 (en) Solid forms for oral administration, said forms containing iphosphamide as active component
HK1004549A1 (en) Carbostyril derivatives and pharmaceutical compositions containing the same for use as a disturbance-of-consciousness improving agent central nervous system stimulant or sigma receptor agonist
ZA916570B (en) Desensitizing dental composition
ATA259590A (de) 3-(n-methyl-n-alkyl)-amino-2-methoxymethylenpro an-1-ol-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
FR2687068B1 (fr) Composition pour empreintes dentaires.
SE9300569D0 (sv) Apparat foer framstaellning av tandfyllningar
ITMI940515V0 (it) Dispositivo simmetropredeterminatore per la riproduzione del tracciato dell'arcata dentale
IL119250A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
IL119403A0 (en) Pharmaceutical composition for the treatment of syndrome X of reaven

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name